Characterization of Central Nervous System Clinico-Genomic Outcomes in ALK-Positive Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Alectinib
Emily Miao(Albert Einstein College of Medicine), Luke Pike(Memorial Sloan Kettering Cancer Center), Henry Walch(Memorial Sloan Kettering Cancer Center), Kathryn Beal(Memorial Sloan Kettering Cancer Center), Brandon S. Imber(Memorial Sloan Kettering Cancer Center), Kenny Yu(Memorial Sloan Kettering Cancer Center), Alicia Meng(Memorial Sloan Kettering Cancer Center), Nikolaus Schultz(Memorial Sloan Kettering Cancer Center), Bob T. Li(Memorial Sloan Kettering Cancer Center), Andreas Rimner(University Medical Center Freiburg), Daniel R. Gomez(Cedars-Sinai Medical Center), Alexander Drilon(Memorial Sloan Kettering Cancer Center), Harper Hubbeling(Memorial Sloan Kettering Cancer Center), Nelson S. Moss(Memorial Sloan Kettering Cancer Center), Jessica Flynn(Memorial Sloan Kettering Cancer Center), Zhigang Zhang(Memorial Sloan Kettering Cancer Center), Emily S. Lebow(University of Pennsylvania), Daniel W. Kelly(Memorial Sloan Kettering Cancer Center), Jordan Eichholz(Memorial Sloan Kettering Cancer Center)
Cited by 9
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.6k
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k